-
Taxonomy & unit
-
dei: shares
-
Description
-
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
-
Summary
-
Summit Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2017 to Q2 2024.
- Summit Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 30, 2024 was 725M shares, a 3.85% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)